6 курс / Гастроэнтерология / Багненко_С_С_Комплексное_магнитно_резонансное_исследование_в_выявлении
.pdf281
J. M. Lee, C. J. Zech, L. Bolondi [et al.] // Korean J. of radiology. – 2011. – Vol. 12,
N4. – P. 403–415.
175.Lee, J. M. Diagnosis of hepatocellular carcinoma: newer radiological tools / J. M. Lee, J. H. Yoon, K. W. Kim // Seminars in oncology. – 2012. – Vol. 39, N 4. –
P.399–409.
176.Lee, M. G. Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtractionangiography / M. G. Lee, K. B. Park, Y. M. Shin [et al.] // World J. of surgery. – 2003. – Vol. 27, N 3.
–P. 278–283.
177.Lee, M. W. Preoperative evaluation of the hepatic vascular anatomy in living liver donors: comparison of CT angiography and MR angiography / M. W. Lee, J. M. Lee, J. Y. Lee [et al.] // J. of magnetic resonance imaging. – 2006. – Vol. 24, N 5.
–P. 1081–1087.
178.Lee, S. S. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques / S. S. Lee, J. H. Byun, H. S. Hong [et al.] // J. of magnetic resonance imaging. – 2007. – Vol. 26, N 2. – P. 323–330.
179.Lewall, D. B. Hepatic echinococcal cyst: sonographic appearance and classification / D. B. Lewall, S. J. McCorkell // Radiology. – 1985. – Vol. 155. – P.773–
775.
180. Leyendecker, J. R. Practical guide to abdominal and pelvic MRI /
J. R. Leyendecker, J. J. Brown, E. M. Merkle. – 2nd ed. – New York; London; Sydney: Lippincott Williams & Wilkins, 2010. – 416 p.
181. Li, B. Diagnostic accuracy of computer tomography angiography and
magnetic resonance angiography in the stenosis detection of autologuous hemodialysis access: a meta-analysis / B. Li, Q. Li, C. Chen [et al.] // PLoS One. – 2013. – Vol. 8, N 10. – P. 78409.
182. Li, Z. J. Experimental study on monitoring gene expression by noninvasive method in rabbit VX2 liver tumor model / Z. J. Li, Y. H. Ma, Q. Liu [et al.] // Zhonghua
282
Gan. Zang. Bing. Za. Zhi. – 2010. – Vol. 18, N 12. – P. 905–908.
183. Lim, A. K. A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease / A. K. Lim, N. Patel, R. J. Eckersley [et al.] // J. of viral hepatitis. – 2011. – Vol. 18,
N10. – P. 530–534.
184.Lim, A. K. P. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C / A. K. P. Lim, N. Patel, G. Hamilton [et al.] // Hepatology. – 2003. – Vol. 37, N 4. – P. 788–794.
185.Lin, J. Budd-Chiari syndrome: diagnosis with three-dimensional contrastenhanced magnetic resonance angiography / J. Lin, X. H. Chen, K. R. Zhou [et al.] // World J. of gastroenterology. – 2003. – Vol. 9, N 10. – P. 2317–2321.
186.Lin, E. Body MRI sequences: a conceptual framework // Applied radiology. – 2012. – Vol. 41, N 1. – P. 16–23.
187.Lin, J. Portal vein involvement by hepatocellular carcinoma: diagnosis with three-dimensional contrast-enhanced MR angiography / J. Lin, K. R. Zhou, J. H. Wang [et al.] // Zhonghua Yi. Xue. Za. Zhi. – 2005. – Vol. 85, N 5. – P. 308–312.
188.Liver cancer study group of Japan: the general rules for the clinical and pathological study of primary liver cancer. – 4th ed. – Tokyo: Kanehara, 2000.
189.Ljungberg, M. 31P MR spectroscopy to evaluate the efficacy of hepatic artery embolization in the treatment of neuroendocrine liver metastases / M. Ljungberg, G. Westberg, B. Vikhoff-Baaz [et al.] // Acta radiologica. – 2012. – Vol. 53б, N 10. –
P.1118–1126.
190.Low, R. N. Abdominal MRI advances in the detection of liver tumours and characterisation // Lancet oncology. – 2007. – Vol. 8, N 6. – P. 525–535.
191.Lu, T. L. Assessment of liver tumor response by high-field (3 T) MRI after radiofrequency ablation: shortand mid-term evolution of diffusion parameters within the ablation zone / T. L. Lu, F. Becce, P. Bize [et al.] // Europ. J. of radiology. – 2012.
–Vol. 81, N 9. – P. 944–950.
192.Macera, A. Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI
|
|
|
283 |
|
|
sequences |
increases |
sensitivity |
and diagnostic accuracy / |
A. Macera, |
C. Lario, |
M. Petracchini [et al.] // Europ. radiology. – 2013. – Vol. 23, N 3. – P. 739–747. |
|||||
193. |
Magnetic |
resonance |
imaging in liver disease |
/ ed. by |
T. J. Vogl, |
R. Lencioni, R. M. Hammersting [et al.]. – Stuttgart; New York: Georg Thieme, 2003. – 260 p.
194. Mandelia, A. The value of magnetic resonance cholangio-pancreatography (MRCP) in the detection of choledocholithiasis / A. Mandelia, A. K. Gupta, D. K. Verma [et al.] // J. of clinical a. diagnostic research. – 2013. – Vol. 7, N 9. –
P.1941–1945.
195.Mannelli, L. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to transarterial chemoembolization: preliminary experience / L. Mannelli, S. Kim, C. H. Hajdu [et al.] // Europ. J. of radiology. – 2013. – Vol. 82, N 4. – P. 577–582.
196. Marotti, M. Magnetic resonance imaging of liver lesions / M. Marotti, R. Klaric-Kustovic, I. Krolo [et al.] // Acta clinica croatica. – 2002. – Vol. 41, suppl. – P. 41–51.
197.Matoba, M. Assessment of functional severity on in vivo hepatic
31P-MRS in diffuse hepatic disease: comparative studies with 99mTc-GSA /
M. Matoba, H. Tonami, H. Yokota [et al.] // Nihon. Igaku. Hoshasen. Gakkai. Zasshi. – 2000. – Vol. 60, N 8. – P. 439–444.
198. Menon, D. K. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis / D. K. Menon, J. Sargentoni, S. D. Taylor-Robinson [et al.] // Hepatology. – 1995. – Vol. 21, N 2. –
P.417–427.
199.Menon, D. K. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcoholic abusters / D. K. Menon, M. Harris, J. Sargentoni [et al.] // Gastroenterology. – 1995. – Vol. 108, N 3. – P. 776–788.
200.Merkle, E. M. Dual gradient-echo in-phase and opposed-phase hepatic MR
imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing |
/ |
E. M. Merkle, R. C. Nelson // RadioGraphics. – 2006. – Vol. 26, N 5. – P. 1409–1418. |
|
284
201. Meyers, A. B. Hepatoblastoma imaging with gadoxetate disodiumenhanced MRI-typical, atypical, preand post-treatment evaluation / A. B. Meyers, A. J. Towbin, J. I. Geller [et al.] // Pediatric radiology. – 2012. – Vol. 42, N 7. – P. 859– 866.
202. Morana, G. Contrast agents for hepatic magnetic resonance imaging /
G. Morana, L. Grazioli, M. Testoni [et al.] // Topics in magnetic rencesona imaging. – 2002. – Vol. 13, N 3. – P. 117–150.
203. Mortelé, K. J. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI / K. J. Mortelé, M. Praet,
H.Van Vlierberghe [et al.] // Abdominal imaging. – 2002. – Vol. 27, N 6. – P. 700–707.
204.Morton, K. A. Diagnostic imaging: nuclear medicine / K. A. Morton,
P.B. Clark, C. R. Christensen [et al.]. – Salt Lake City (Utah): Amirsys, 2007. – 860 p.
205.MRI Handbook: MR physics, patient positioning, and protocols / ed. by M. Elmaoğlu, A. Çelik. – New York: Springer, 2012. – 318 p.
206.MRI of the liver / ed. by G. Schneider, L. Grazioli, S. Saini. – 2nd ed. –
Milan; Berlin; Heidelberg; New York: Springer, 2006. – 432 p.
207. MRI of the liver: a practical guide / ed. by P. J. A. Robinson, J. Ward . – New York: Taylor & Francis Group, 2006. – 398 p.
208. Muhi, A. Diffusionand T2-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium / A. Muhi, T. Ichikawa, U. Motosugi [et al.] // Magnetic resonance in med. sciences. – 2012. – Vol. 11, N 3. –
P.185–191.
209.Murakami, Y. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma / Y. Murakami, K. Uemura, T. Sudo, [et al.] // Annals of surgical oncology. – 2011. – Vol. 18. – P. 651–658.
210.Naito, K. Optimization of flip angle for 3D-VIBE technique in liver dynamic MRI / K. Naito, Y. Ohgoshi, M. Ohkubo [et al.] // Nihon Hoshasen Gijutsu Gakkai Zasshi. – 2005. – Vol. 61, N 10. – P. 1441–1446.
211.Nakamura, S. Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver
285
function correlate with enhancement? / S. Nakamura, K. Awai, D. Utsunomiya [et al.] //
Jap. J. of radiology. – 2012. – Vol. 30, N 1. – P. 25–33.
212.Nakamura, S. The diagnosis of hypovascular hepatic lesions showing hypointensity in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in highrisk patients for hepatocellular carcinoma / S. Nakamura, K. Nouso, Y. Kobayashi [et al.] // Acta medica Okayama. – 2013. – Vol. 67, N 4. – P. 239–244.
213.Nakanishi, M. Relationship between diffusion-weighted magnetic
resonance |
imaging and histological tumor grading of hepatocellular carcinoma |
/ |
M. Nakanishi, M. Chuma, S. Hige [et al.] // Annals of surgical oncology. – 2012. |
– |
|
Vol. 19, N 4. – P. 1302–1309. |
|
|
214. |
Namasivayam, S. Imaging of liver metastases: MRI / S. Namasivayam, |
D.R. Martin, S. Saini // Cancer imaging. – 2007. – Vol. 7, N 1. – P. 2–9.
215.Noren, B. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy / B. Noren, O. Dahlqvist, P. Lundberg [et al.] // Europ. J. of radiology. – 2008. – Vol. 66, N 2. – P. 313–320.
216.Nuclear magnetic resonance / eds. G. A. Webb, K. Kamienska-Trela. –
Cambridge, 2010. – 512 p. – (Specialist periodical reports / Royal soc. of chemistry: vol. 39).
217. Numminem, K. Magnetic resonance imaging of the liver: true fast imaging with steady state free precession sequence facilitates rapid and reliable distinction between hepatic hemangiomas and liver malignancies / K. Numminem, J. Halavaara, H. Isoniemi [et al.] // J. of computer assisted tomography. – 2003. – Vol. 27. – P. 571– 576.
218.Okada, M. Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function? / M. Okada, K. Ishii, K. Numata [et al.] // Hepatobiliary a. pancreatic diseases intern. – 2012. – Vol. 11, N 3. – P. 307–313.
219.Palmucci, S. Diffusion-weighted MRI in a liver protocol: its role in focal lesion detection / S. Palmucci, L. A. Mauro, M. Messina [et al.] // World J. of radiology.
–2012. – Vol. 4, N 7. – P. 302–310.
220.Parikh, T. Focal liver lesion detection and characterization with diffusion-
286
weighted MR imaging: comparison with standard breath-hold T2-weighted imaging /
T.Parikh, S. J. Drew, V. S. Lee [et al.] // Radiology. – 2008. – Vol. 246. – P. 812–822.
221.Park, M. J. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for smallhepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis / M. J. Park, Y. K. Kim, M. H. Lee [et al.] // Acta radiologica. – 2013. – Vol. 54, N 2. – P. 127–136.
222.Park, M. S. Hepatocellular carcinoma: detection with diffusion-weighted
versus contrast-enhanced magnetic resonance imaging in pretransplant patients /
M.S. Park, S. Kim, J. Patel [et al.] // Hepatology. – 2012. – Vol. 56, N 1. – P. 140–148.
223.Patel, T. Cholangiocarcinoma-controversies and challenges // Nature rev. gastroenterology a. hepatology. – 2011. – Vol. 8. – P. 189–200.
224.Pedrosa, I. Hydatid disease: radiologic and pathologic features and complications / I. Pedrosa, A. Saiz, J. Arrazola [et al.] // RadioGraphics. – 2000. –
Vol. 20. – P. 795–817.
225.Permutt, Z. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease. MRI accurately quantifies hepatic steatosis in NAFLD / Z. Permutt, T. A. Le, M. R. Peterson [et al.] // Alimentary pharmacology a. therapeutics. – 2012. – Vol. 36, N 1. – P. 22–29.
226.Pradella, S. Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma / S. Pradella, S. Lucarini, S. Colagrande
/Amer. J. of roentgenology. – 2012. – Vol. 199, N 5. – P. W662–W662.
227. |
Prince, M. R. 3D Contrast |
MR angiography / M. R. Prince, T. M. Grist, |
J. F. Debatin. – Berlin; Heidelberg; New York: Springer, 2003. – 300 p. |
||
228. |
Problem solving in |
abdominal imaging / N. C. Dalrymple, |
J.R. Leyendecker, M. Oliphant. – Philadelphia (Pa): Elsevier Mosby, 2009. – 670 p.
229.Qi, J. 31P MR spectroscopic imaging detects regenerative changes in human liver stimulated by portal vein embolization / J. Qi, A. Shukla-Dave, Y. Fong [et al.] // J. of magnetic resonance imaging. – 2011. – Vol. 34, N 2. – P. 336–344.
230.Quaia, E. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease
287
of the liver: diagnostic performance and confidence / E. Quaia, M. D'Onofrio,
A.Palumbo [et al.] // Europ. radiology. – 2006. – Vol. 16, N 7. – P. 1599–1609.
231.Radulovic, D. The utility of TrueFISP in abdominal imaging: analysis of
vascular assessment and liver lesion detection |
[Electronic research] / |
D. Radulovic, |
I. D. Kirkpatrick, M. A. Kroeker, N. Pawlyshyn |
// Proc. Intern. soc. |
for magnetic |
resonance in medicine. – 2006. – Vol. 14. – URL: http://cds.ismrm.org/ismrm-
2006/files/00846.pdf
232. Ramalho, M. In-phase and out-of-phase gradient-echo imaging in abdominal studies: intra-individual comparison of three different techniques /
M. Ramalho, V. Herédia, R. O. de Campos [et al.] // Acta radiologica. – 2012. – Vol. 53, N 4. – P. 441–449.
233. Reimer, P. Clinical MR imaging: a |
practical approach / P. Reimer, |
P. M. Parizel, F. A. Stichnoth. – 2nd ed. – Berlin; |
Heidelberg; New York: Springer, |
2010. – 874 p. |
|
234.Rengier, F. State-of-the-art aortic imaging. Pt. 1. Fundamentals and perspectives of CT and MRI / F. Rengier, P. Geisbüsch, R. Vosshenrich [et al.] // Ztschr. für Gefässkrankheiten = J. for vascular diseases: VASA. – 2013. – Vol. 42, N 6.
–P. 395–412.
235.Rosenkrantz, A. B. Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity / A. B. Rosenkrantz, L. Lee, B. W. Matza, S. Kim // Clinical radiology. – 2012. – Vol. 67, N 12. – P. 105–111.
236.Saenz, R. C. MRI of benign liver lesions and metastatic disease characterization with gadoxetate disodium // J. of Amer. osteopathic college of radiology. – 2012. – Vol. 1, N 4. – P. 2–9.
237. |
Sai, J. MRCP. Early diagnosis of |
pancreatobiliary |
diseases |
/ J. Sai, |
||
J. Ariyama. – Tokyo [etc.]: Springer, 2000. – 155 p. |
|
|
|
|||
238. |
Saito, K. |
Assessing |
liver |
function |
using |
dynamic |
Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol / K. Saito, J. Ledsam, S. Sourbron [et al.] // J. of magnetic resonance imaging. – 2013. – Vol. 37, N 5. – P. 1109–1114.
288
239. Sandrasegaran, K. State-of-the-Art Pancreatic MRI / K. Sandrasegaran, C. Lin, F. M. Akisik [et al.] // Amer. J. of roentgenology: AJR. – 2010. – Vol. 195. –
P.42–53.
240.Sandrasegaran, K. The value of diffusion-weighted imaging in characterizing focal liver masses / K. Sandrasegaran, F. M. Akisik., C. Lin [et al.] // Acad. radiology. – 2009. – Vol. 16, N 10. – P. 1208–1214.
241.Sasaki, K. Small hepatic lesions found on single-phase helical CT in patients with malignancy: diagnostic capability of breath-hold, multisection fluidattenuated inversion-recovery (FLAIR) MR imaging using a half-fourier acquisition single-shot turbo spin-echo (HASTE) sequence / K. Sasaki, K. Ito, T. Fujita [et al.] // J. of magnetic resonance imaging. – 2007. – Vol. 25, N 1. – P. 129–136.
242.Schaefer-Prokop, C. M. Critical care radiology / C. M. Schaefer-Prokop. –
Stuttgart: Thieme, 2011. – 236 p.
243. Schuhmann-Giampieri, G. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system / G. Schuhmann-Giampieri, H. Schmitt-Willich, W. R. Press [et al.] // Radiology. – 1992. – Vol. 183, N 1. – P. 59– 64.
244. Semelka, R. C. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement / R. C. Semelka, D. R. Martin, C. Balci // J. of magnetic resonance imaging. – 2001. – Vol. 13, N 3. – P. 397–401.
245. Seo, H. J. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases / H. J. Seo, M. J. Kim, J. D. Lee [et al.] // Investigative radiology. – 2011. – Vol. 46, N 9.
–P. 548–555.
246.Sevastianova, K. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling / K. Sevastianova, A. Hakkarainen, A. Kotronen [et al.] // Radiology. – 2010. – Vol. 256, N 2. – P. 466–473.
289
247. Shimoda, M. Multi-disciplinary treatment for cholangiocellular carcinoma /
M. Shimoda, K. Kubota // World J. of gastroenterology. – 2007. – Vol. 13, N 10. – P. 1500–1504.
248. Sibulesky, L. Preneoplastic conditions underlying bile duct cancer / L. Sibulesky, J. Nguyen, T. Patel // Langenbeck’s arch. of surgery. – 2012. – Vol. 397,
N6. – P. 861–867.
249.Siegelman, E. S. Body MRI / E. S. Siegelman. – Philadelphia (Pa): Elsevier Saunders, 2005. – 527 p.
250.Sijens, P. E. Parametric exploration of the liver by magnetic resonance methods // Europ. radiology. – 2009. – Vol. 19, N 11. – P. 2594–2607.
251.Sodickson, A. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques / A. Sodickson, K. J. Mortele, M. A. Barish [et al.] // Radiology. – 2006. – Vol. 238, N 2. – P. 549–559.
252.Sofue, K. Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after
injection for the detection of liver metastases from colorectal carcinoma / K. Sofue, M. Tsurusaki, H. Tokue [et al.] // Europ. radiology. – 2011. – Vol. 21, N 11. – P. 2336– 2343.
253.Solga, S. F. Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide / S. F. Solga, A. Horska, J. M. Clark [et al.] // Liver intern. – 2005. – Vol. 25, N 3. – P. 490–500.
254.Sommer, W. H. Contrast agents as a biological marker in magnetic
resonance imaging of the liver: conventional and new approaches / W. H. Sommer, S. Sourbron, A. Huppertz [et al.] // Abdominal imaging. – 2012. – Vol. 37, N 2. –
P.164–179.
255.Song, K. D. Detection and characterization of small focal hepatic lesions
(≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T / K. D. Song, Y. K. Kim, W. J. Lee [et al.] // Acta radiologica. – 2012. – Vol. 53, N 5. – P. 485–493.
256. Soyer, P. Differentiation between cavernous hemangiomas and untreated
290
malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging:
comparison |
with T2-weighted fast spin-echo MR imaging / P. Soyer, L. Corno, |
|||
M. Boudiaf [et al.] // Europ. J. of radiology. – 2011. – Vol. 80, N 2. – P. 316–324. |
|
|||
257. |
Stark, D. D. Chronic liver disease: evaluation |
by magnetic |
resonance |
/ |
D. D. Stark, |
H. I. Goldberg, A. A. Moss // Radiology. – |
1984. – Vol. |
150, N 1. |
– |
P.149–15l.
258.Stark, D. D. NMR of experimentally induced liver disease / D. D. Stark, N.-M. Bass, A. A. Moss // Radiology. – 1983. – Vol. 148, N 3. – P. 743–751.
259.Stejskal, E. O. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient / E. O. Stejskal, J. E. Tanner // J. of chemical physics. –
1965. – Vol. 42. – P. 288–292.
260. Stork, A. Comparison of an edema-sensitive HASTE-TIRM sequence with delayed contrast enhancement in acute myocardial infarcts / A. Stork, G. K. Lund, M. Bansmann [et al.] // Fortschritte auf dem Gebiete der Röntgenstrahlen und der
Nuklearmedizin: RöFo. – 2003. – Vol. 175, N 2. – P. 194–198.
261.Sun, J. Z. Evaluation of biochemical metabolites by 31P MR spectroscopy in leukemic infiltration of liver / J. Z. Sun, Z. K. Wang, R. S. Yu [et al.] // Zhejiang Da Xue. Xue. Bao. Yi. Xu. Ban. – 2010. – Vol. 39, N 2. – P. 150–156.
262.Szurowska, E. Predictive value of apparent diffusion coefficient in evaluation of colorectal carcinoma hepatic metastases' response to radiofrequency ablation / E. Szurowska, T. K. Nowicki, E. Izycka-Swieszewska [et al.] // J. of magnetic resonance imaging. – 2013. – Vol. 38, N 5. – P. 1027–1032.
263.Takao, H. MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity / H. Takao, H. Akai, T. Tajima [et al.] // Europ. J. of radiology. – 2011. – Vol. 77, N 2. – P. 325–329.
264.Tamada, T. Simple method for evaluating the degree of liver parenchymal enhancement in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging / T. Tamada, K. Ito, A. Yamamoto [et al.] // J. of magnetic resonance imaging.
–2013. – Vol. 37, N 5. – P. 1115–1121.
265.Taouli, B. Evaluation of liver diffusion isotropy and characterization of